Core Viewpoint - Southbound funds have increased their holdings in Baize Medical (02609.HK) by 216,600 shares on February 27, indicating growing investor interest in the company [1] Group 1: Southbound Fund Activity - In the last 5 trading days, southbound funds have increased their holdings for 5 days, with a total net increase of 4.476 million shares [1] - Over the past 20 trading days, there have been 11 days of net increases, totaling 7.401 million shares [1] - Currently, southbound funds hold 75.921 million shares of Baize Medical, representing 5.75% of the company's issued ordinary shares [1] Group 2: Company Overview - Baize Medical Group primarily engages in investment and provision of medical-related services, focusing on oncology [1] - The company offers comprehensive oncology services, including screening, diagnosis, treatment, and rehabilitation [1] - Its business operations include hospital services, hospital management, supply of pharmaceuticals, medical devices, consumables, and other related services [1] - The company also conducts early cancer screening, tumor vaccination, and health management services for potential healthy populations [1] - Baize Medical primarily operates in the Chinese market [1]
佰泽医疗（02609.HK）：2月27日南向资金增持21.66万股